Northwest Pipe Co
F:NW7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Northwest Pipe Co
F:NW7
|
US |
|
L
|
Linde PLC
F:LIN
|
UK |
|
Cytek Biosciences Inc
F:8EQ
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XMUN:MUV2
|
DE |
|
I
|
InterDigital Inc
F:IDI
|
US |
|
A
|
Aytu Biopharma Inc
F:AY20
|
US |
|
G
|
Goldman Sachs BDC Inc
SWB:GSB
|
US |
|
C
|
Chargeurs SA
F:GET
|
FR |
|
Atlanta Braves Holdings Inc
F:E450
|
US |
|
Varia US Properties AG
F:VAU
|
CH |
Wall St Price Targets
NW7 Price Targets Summary
Northwest Pipe Co
According to Wall Street analysts, the average 1-year price target for NW7 is 39.04 EUR with a low forecast of 32.9 EUR and a high forecast of 46.17 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NW7's stock price target?
Price Target
39.04
EUR
According to Wall Street analysts, the average 1-year price target for NW7 is 39.04 EUR with a low forecast of 32.9 EUR and a high forecast of 46.17 EUR.
What is the Revenue forecast for Northwest Pipe Co?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 4 years is 3%.
What is the Operating Income forecast for Northwest Pipe Co?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 4 years is 7%.
What is the Net Income forecast for Northwest Pipe Co?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 9%.
